In a current examine, we described the identification and the characterization of a new atypical opioid receptor with special adverse regulatory Houses in direction of opioid peptides.1 Our success confirmed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a broad-spectrum scaveng